Matikas, A., Liu, X., Acs, B., Hartman, J., Foukakis, T., Valachis, A. (2026). A nationwide population-based study on the incidence and prognosis of patients with HER2+ breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12508